feed

S&P 500—

NASDAQ—

DOW—

RUSSELL—

VIX—

US10Y—

DXY—

EUR/USD—

GBP/USD—

GOLD—

WTI—

BTC—

ETH—

AArphraTerminal

Arphra/Issuer/VTRS

VTRS

Viatris Inc.

HealthcareDrug Manufacturers - Specialty & GenericUSUSD

$16.26

+1.88%Live · FMPMay 29, 2026

Market cap

$18.94B

52w range

8.40 – 17.53

P / E

—

EPS

—

Volume

16.93M

Revenue · FY

$14.3B

-2.98% YoY

Press releasestopic:all earnings guidance dividend buyback mna ipo split layoffs lawsuit regulation rating executive product macro

News sentiment · 90d

DB · scored

2026-05-01 bullish neutral bearish2026-05-12

Topic mix · 30d

DB · scored

executive—2
product1.002
earnings1.001
guidance1.001
rating1.001

News

DB · scored8

Viatris Inc. (VTRS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
May 12, 2026Seeking Alpha
Why Viatris (VTRS) is a Top Growth Stock for the Long-Term+1.00
May 12, 2026Zacks Investment Research
Viatris: From Cost Story To Pipeline-Driven Re-Rating (Rating Upgrade)+1.00
May 12, 2026Seeking Alpharating product
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
May 07, 2026PRNewsWire
Viatris Reports First-Quarter 2026 Financial Results+1.00
May 07, 2026PRNewsWireearnings guidance product
Viatris Announces Chief Financial Officer Transition
May 04, 2026PRNewsWireexecutive
Viatris Announces Chief Financial Officer Transition
May 04, 2026PRNewsWireexecutive
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting
May 01, 2026PRNewsWire